Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
We will investigate the clinical manifestations and molecular genetic defects of heritable urologic malignant disorders. Families with urologic malignancy with known or suspected genetic basis will be enrolled. Affected individuals or individuals suspected of having a germline urologic malignant disorder will undergo periodic clinical assessment and genetic analyses for the purpose of: 1) definition and characterization of phenotype, 2) determination of the natural history of the disorder, and 3) genotype/phenotype correlation. Genetic linkage studies may be performed in situations in which the genetic basis of the disorder has not been elucidated. ...
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 2 lata
- •Osoba lub członkowie rodziny biologicznej z podejrzeniem lub potwierdzoną diagnozą dziedzicznego nowotworu układu moczowego
- •Osoba z potwierdzoną lub podejrzewającą mutacją genu VHL lub innymi znanymi genetycznymi przyczynami nowotworów nerek
- •Rodzina z wieloma przypadkami tego samego lub pokrewnego nowotworu w historii
- •Osoby z cystami nerek lub rakiem nerki w podejrzeniu przyczyn genetycznych
- •Opiekun prawny musi podpisać zgodę dla pacjentów poniżej 18 lat
Simplified criteria — AI translation
Trial details
- Minimum age
- 2 Years
- Last updated (source)
- July 23, 2026
- Sex
- No restrictions
Locations (1)
National Institutes of Health Clinical Center
Bethesda, United States
Trial contact
Deborah A Nielsen, R.N.
W. Marston Linehan, M.D.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.